Gilead Sciences (NASDAQ: GILD) reported Q2 EPS of $3.15, $0.44 better than the analyst estimate of $2.71. Revenue for the quarter came in at $8.24 billion versus the consensus estimate of $7.61 billion.

For earnings history and earnings-related data on Gilead Sciences (GILD) click here.

Earnings Hot Earnings

Gilead Sciences' (GILD) Price Target Bumped to $135 at Deutsche BankJuly 29, 2015 10:13 AM Gilead Sciences (GILD) PT Raised to $134 at Piper Jaffray on Another 'Beat and Raise'July 29, 2015 9:10 AM Gilead Sciences (GILD) PT Lifted to $135 at Baird on Strong Earnings BeatJuly 29, 2015 6:58 AM Gilead Sciences (GILD) PT Raised to $120 at Oppenheimer on Solid Q2 BeatJuly 29, 2015 6:28 AM Gilead Sciences (GILD) Declares $0.43 Quarterly Dividend; 1.5% YieldJuly 28, 2015 5:18 PM Gilead Sciences Announces Third Quarter 2015 DividendJuly 28, 2015 4:02 PM